139 related articles for article (PubMed ID: 18053089)
1. NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression.
Baugé C; Beauchef G; Leclercq S; Kim SJ; Pujol JP; Galéra P; Boumédiene K
J Cell Mol Med; 2008; 12(5A):1754-66. PubMed ID: 18053089
[TBL] [Abstract][Full Text] [Related]
2. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes.
Chadjichristos C; Ghayor C; Kypriotou M; Martin G; Renard E; Ala-Kokko L; Suske G; de Crombrugghe B; Pujol JP; Galéra P
J Biol Chem; 2003 Oct; 278(41):39762-72. PubMed ID: 12888570
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter.
Porée B; Kypriotou M; Chadjichristos C; Beauchef G; Renard E; Legendre F; Melin M; Gueret S; Hartmann DJ; Malléin-Gerin F; Pujol JP; Boumediene K; Galéra P
J Biol Chem; 2008 Feb; 283(8):4850-65. PubMed ID: 18065760
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio.
Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P
J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
[TBL] [Abstract][Full Text] [Related]
7. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
Liu Y; Zhong X; Li W; Brattain MG; Banerji SS
J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860
[TBL] [Abstract][Full Text] [Related]
8. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts.
Chang W; Parra M; Ji C; Liu Y; Eickelberg O; McCarthy TL; Centrella M
Gene; 2002 Oct; 299(1-2):65-77. PubMed ID: 12459253
[TBL] [Abstract][Full Text] [Related]
10. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
Ammanamanchi S; Brattain MG
J Biol Chem; 2001 Aug; 276(35):32854-9. PubMed ID: 11443124
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes.
Baugé C; Attia J; Leclercq S; Pujol JP; Galéra P; Boumédiene K
Arthritis Rheum; 2008 Jan; 58(1):221-6. PubMed ID: 18163503
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts.
He T; Quan T; Fisher GJ
Exp Dermatol; 2014 Oct; 23 Suppl 1(0 1):2-6. PubMed ID: 25234828
[TBL] [Abstract][Full Text] [Related]
13. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
Hypes MK; Pirisi L; Creek KE
Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
[TBL] [Abstract][Full Text] [Related]
15. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
Liu J; Yang H; Liu W; Cao X; Feng X
J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
[TBL] [Abstract][Full Text] [Related]
16. Xylosyltransferase-1 expression is refractory to inhibition by the inflammatory cytokines tumor necrosis factor α and IL-1β in nucleus pulposus cells: novel regulation by AP-1, Sp1, and Sp3.
Ye W; Zhou J; Markova DZ; Tian Y; Li J; Anderson DG; Shapiro IM; Risbud MV
Am J Pathol; 2015 Feb; 185(2):485-95. PubMed ID: 25476526
[TBL] [Abstract][Full Text] [Related]
17. Sp3 Transcription Factor Cooperates with the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein To Synergistically Activate Specific Viral and Cellular Gene Promoters.
Chen LY; Chen LW; Peng KT; Hung CH; Chang PJ; Wang SS
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641483
[TBL] [Abstract][Full Text] [Related]
18. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
Song K; Wang H; Krebs TL; Kim SJ; Danielpour D
Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577
[TBL] [Abstract][Full Text] [Related]
19. Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor.
Ji C; Casinghino S; McCarthy TL; Centrella M
J Biol Chem; 1997 Aug; 272(34):21260-7. PubMed ID: 9261136
[TBL] [Abstract][Full Text] [Related]
20. Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene.
Ou XM; Chen K; Shih JC
J Biol Chem; 2004 May; 279(20):21021-8. PubMed ID: 15024015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
